Cancer Research Institute

03/15/2026

While the annual rate of new kidney cancer diagnoses has been rising for years, mortality rates have been decreasing. This encouraging trend reflects advances in treatment and in care- helping more people live longer with the disease.

Learn more during March's Kidney Cancer Awareness Month:

Learn about kidney cancer during Kidney Cancer Awareness Month, including how immunotherapy is transforming treatment options and ongoing research.

03/14/2026

🌟 "It’s really, really crucial to make sure that the brightest, best scientists are focusing their efforts on treatments that will help people prolong our lives and maybe even cure people that were incurable," describes stage 4 colorectal cancer survivor, Gordon.

Hear more: https://bit.ly/403f3gW

After exhausting nearly every option for stage 4 colorectal cancer, Gordon Levine found new hope in immunotherapy. Today, he's cancer-free and advocating for more patients to get the same second chance.

03/13/2026

Experts estimate that more than half of the colorectal cancer cases in the US may be linked to modifiable risk factors, including diet, physical inactivity, smoking, and alcohol use.

Understanding these risks, and taking proactive steps, can make a meaningful difference. Get more info during March's Colorectal Cancer Awareness Month: https://bit.ly/4aLHCEk

03/12/2026

What cancers can be treated with immunotherapy? Learn how immunotherapy helps your immune system fight cancer, and discover what cancers it can treat: https://bit.ly/3YKAtxQ

Explore different kinds of treatment for various cancers, why immunotherapy matters, and how to support cancer immunotherapy research.

03/11/2026

Peggy, a stage 4 kidney cancer survivor, encourages patients to ask questions, and to seek second opinions if needed.

“When you hear you have cancer, your brain goes to mush,” Peggy says. “Then you are asked to be part of the decision-making team for your treatment. Another patient who has had a similar experience and can explain what it means to manage immune side effects or recover from surgery — that can be invaluable.” More: https://bit.ly/3P14ysf

After a stage 4 kidney cancer diagnosis, immunotherapy put Peggy Zuckerman into lasting remission. Today, she helps patients find clarity and confidence.

03/10/2026

📈 February's IO360 Summit showcased decade-long survival data, next-generation therapies, and artificial intelligence applications, highlighting how far the field has progressed, and where it may be headed next.

↪️ Review CRI's key takeaways from the three-day long event, in our new blog post: https://bit.ly/40RWbBJ

IO360° Summit highlights: melanoma survival milestones, next-generation CAR T therapies, AI in cancer research, and new immunotherapy treatments transforming outcomes.

03/09/2026

Explore key prevention strategies, review ongoing research, and discover how immunotherapy is transforming treatment options for kidney cancer patients, during Kidney Cancer Awareness Month: https://bit.ly/4aYovZd

03/08/2026

During March's Colorectal Cancer Awareness Month, Gordon, a stage 4 colorectal cancer survivor, has a simple message to share- stop avoiding the conversation- and get screened. Learn more: https://bit.ly/403f3gW

03/07/2026

How could federal funding cuts affect advances in cancer research, and influence young researchers to leave the field? CRI's CEO, Dr. Alicia Zhou, discusses the real-world impact today, and its implications on future innovation, with Public News Service: https://bit.ly/4bnpa6y

The American Cancer Society estimates more than 18,000 Mississippians will be diagnosed with cancer this year.Cancer survival rates are at a historic high but medical professionals are concerned about potential

03/06/2026

"AI will help us decode cancer’s complexity. But algorithms alone will not save lives. The real work is building the shared foundation that allows intelligence (both human and artificial) to learn together," says CRI's CEO, Dr. Alicia Zhou. "If we get that right, we can compress decades of discovery into years."

"For patients, that time isn’t a trivial metric. It’s survival."

Learn how CRI is building the foundation to tackle fragmented silos in machine learning, in order to unlock lifesaving breakthroughs in immunotherapy, through the CRI Discovery Engine. Explore with World Economic Forum: https://bit.ly/4bq5crN

Enormous shared datasets enabled modern AI to master complex tasks. But fragmented data silos currently prevent machine learning from unlocking life-saving breakthroughs in cancer immunotherapy.

03/05/2026

More than half of early onset colorectal cancers have been linked to non-genetic risk factors such as smoking, unhealthy diet, high alcohol intake, and physical inactivity, The Hill describes. Understand how early detection and lifestyle shifts could help lower colorectal cancer rates: https://bit.ly/3OZbUMF

The rate of colorectal cancer is increasing among younger Americans and is now the leading cause of cancer deaths in adults under the age of 50, according to research published by the American Canc…

03/04/2026

"Some of the very same lifestyle-related factors can set patients up for both cancer and cardiovascular disease," explains Mayo Clinic's Dr. Herrmann. "Smoking is a prime example."

↘️ Read an expert's tips to reduce your risk:

Learn how cancer and heart disease are connected and what you can do to lower your risk, according to a Mayo Clinic cardio-oncology expert during Heart Month.